Andrew Scholey

Prof. Andrew Scholey

Centre for Human Psychopharmacology, Swinburne University, Melbourne, VIC 3122, Australia
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
ATAnne-Laure Tardy
Anne-Laure Tardy
EPEtienne Pouteau
Etienne Pouteau
DMDaniel Marquez
Daniel Marquez
CYCansu Yilmaz
Cansu Yilmaz
ASAndrew Scholey
Andrew Scholey
Vitamins and minerals are essential to humans as they play essential roles in a variety of basic metabolic pathways that support fundamental cellular functions. In particular, their involvement in energy-yielding metabolism, DNA synthesis, oxygen transport, and neuronal functions makes them critical for brain and muscular function. These, in turn, translate into effects on cognitive and psychological processes, including mental and physical fatigue. This review is focused on B vitamins (B1, B2, B3, B5, B6, B8, B9 and B12), vitamin C, iron, magnesium and zinc, which have recognized roles in these outcomes. It summarizes the biochemical bases and actions of these micronutrients at both the molecular and cellular levels and connects them with cognitive and psychological symptoms, as well as manifestations of fatigue that may occur when status or supplies of these micronutrients are not adequate.

1 March 2015 in The Lancet Psychiatry
Verified
Journal Article
Closed access
JSJerome Sarris
Jerome Sarris
ALAlan C Logan
Alan C Logan
TATasnime N Akbaraly
Tasnime N Akbaraly
GAG Paul Amminger
G Paul Amminger
Vicent Balanzá-MartínezVicent Balanzá-Martínez
Vicent Balanzá-Martínez
FJFelice N Jacka
Felice N Jacka

1 December 2011 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
JSJerome Sarris
Jerome Sarris
Alexander PanossianAlexander Panossian
Alexander Panossian
ISIsaac Schweitzer
Isaac Schweitzer
CSCon Stough
Con Stough
ASAndrew Scholey
Andrew Scholey

2 October 2014 in Journal of Psychopharmacology
Verified
Journal Article
Closed access
KCKatherine Hm Cox
Katherine Hm Cox
APAndrew Pipingas
Andrew Pipingas
ASAndrew Scholey
Andrew Scholey
Curcumin possesses many properties which may prevent or ameliorate pathological processes underlying age-related cognitive decline, dementia or mood disorders. These benefits in preclinical studies have not been established in humans. This randomized, double-blind, placebo-controlled trial examined the acute (1 and 3 h after a single dose), chronic (4 weeks) and acute-on-chronic (1 and 3 h after single dose following chronic treatment) effects of solid lipid curcumin formulation (400 mg as Longvida®) on cognitive function, mood and blood biomarkers in 60 healthy adults aged 60–85. One hour after administration curcumin significantly improved performance on sustained attention and working memory tasks, compared with placebo. Working memory and mood (general fatigue and change in state calmness, contentedness and fatigue induced by psychological stress) were significantly better following chronic treatment. A significant acute-on-chronic treatment effect on alertness and contentedness was also observed. Curcumin was associated with significantly reduced total and LDL cholesterol and had no effect on hematological safety measures. To our knowledge this is the first study to examine the effects of curcumin on cognition and mood in a healthy older population or to examine any acute behavioral effects in humans. Results highlight the need for further investigation of the potential psychological and cognitive benefits of curcumin in an older population.

28 January 2005 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
CHCrystal F. Haskell
Crystal F. Haskell
DKDavid Kennedy
David Kennedy
KWKeith A. Wesnes
Keith A. Wesnes
ASAndrew Scholey
Andrew Scholey

26 November 2009 in Journal of Psychopharmacology
Verified
Journal Article
Closed access
PDF file
ASAndrew Scholey
Andrew Scholey
SFStephen J French
Stephen J French
PMPenelope J Morris
Penelope J Morris
DKDavid Kennedy
David Kennedy
AMAnthea L Milne
Anthea L Milne
CHCrystal F Haskell
Crystal F Haskell
Cocoa flavanols (CF) positively influence physiological processes in ways that suggest their consumption may improve aspects of cognitive function. This study investigated the acute cognitive and subjective effects of CF consumption during sustained mental demand. In this randomized, controlled, double-blinded, balanced, three period crossover trial 30 healthy adults consumed drinks containing 520 mg, 994 mg CF and a matched control, with a three-day washout between drinks. Assessments included the state anxiety inventory and repeated 10-min cycles of a Cognitive Demand Battery comprising of two serial subtraction tasks (Serial Threes and Serial Sevens), a Rapid Visual Information Processing (RVIP) task and a ‘mental fatigue’ scale, over the course of 1 h. Consumption of both 520 mg and 994 mg CF significantly improved Serial Threes performance. The 994 mg CF beverage significantly speeded RVIP responses but also resulted in more errors during Serial Sevens. Increases in self-reported ‘mental fatigue’ were significantly attenuated by the consumption of the 520 mg CF beverage only. This is the first report of acute cognitive improvements following CF consumption in healthy adults. While the mechanisms underlying the effects are unknown they may be related to known effects of CF on endothelial function and blood flow.